TF Capital is an institutional investor (Conventional VCs) founded in 2013 and headquartered in Shanghai, China. Zai Lab Limited(NASDAQ:ZLAB)research-based, commercial stage biopharmaceutical company based in China and the U. Click for MoreHenlius (HK:2696)a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Click for MoreDreamCIS (KOSDAQ:223250)the largest CRO in Korea dedicated to provide clinical research services with over 1,200 successful projects to the pharmaceuticals, biotechnology, medical device and functional food industries. VC firm focused on early stage investments. Assets Under Management (AUM): $1BAUM. Notable portfolio companies: TF Capital has invested in nearly 100 companies, including successful NASDAQ, HKG, ChiNext Board and STAR market IPOs.

Stage

Early Stage, Early Stage

HQ

Shanghai, china

Founded

2013

Website

https://www.tfcapital.net/

LinkedIn

https://linkedin.com/company/%E6%B3%B0%E7%A6%8F%E8%B5%84%E6%9C%AC-tf-capital

Preparing to pitch TF Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.